In vivo suicide gene therapy model using a newly discovered prostate-specific membrane antigen promoter/enhancer: a potential alternative approach to androgen deprivation therapy
Author:
Publisher
Elsevier BV
Subject
Urology
Reference26 articles.
1. Chodak GW, Vogelzang NJ, Caplan RJ, et al: Independent prognostic factors in patients with metastatic (stage D2) prostate cancer: the Zoladex Study Group. JAMA 265: 618–621, 1991.
2. The Leuprolide Study Group: Leuprolide versus diethylstilbestrol for metastatic prostate cancer. N Engl J Med 311: 1281–1286, 1984.
3. Adenoviral transduction of a cytosine deaminase/thymidine kinase fusion gene into prostate carcinoma cells enhances prodrug and radiation sensitivity;Blackburn;Int J Cancer,1999
4. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer;Gotoh;J Urol,1998
5. Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer;Hall;Int J Cancer,1997
Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Applications of tissue-specific and cancer-selective gene promoters for cancer diagnosis and therapy;Advances in Cancer Research;2023
2. A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals;European Journal of Nuclear Medicine and Molecular Imaging;2021-01-25
3. PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates;International Journal of Molecular Sciences;2018-10-19
4. Integrated Proteomic and Glycoproteomic Analyses of Prostate Cancer Cells Reveal Glycoprotein Alteration in Protein Abundance and Glycosylation*;Molecular & Cellular Proteomics;2015-10
5. Targeted Prodrug Approaches for Hormone Refractory Prostate Cancer;Medicinal Research Reviews;2014-12-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3